Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Loading...

Submitting the form, please do not close the page and
ensure that your network is smooth to avoid the email being unable to be sent.

bassic_bn

Basic Information

Home > Investor > Basic Information

Maxigen Biotech Inc. (MBI) was founded in December 1998. Next year, MBI stationed at National Yang-Ming University and set up an incubation center at there to conduct the R&D work of collagen. MBI utilizes its core competence in biopolymers and has developed a broad range of applications in areas such as medical devices and skincare products. MBI has been dedicated to the development and application medical device of collagen and hyaluronic acid. Headquarters was moved to Hwa-Ya Technology park in July 2016. Our major shareholders include TCI Bio, GIH Group, and – NuVasive Inc., a Nasdaq-listed medical device company in the US.

Company Profile

Company Name Maxigen Biotech Inc.
Stock Code 1783
Industry Category Medical Care, Beauty, Biotechnology
Company Address No.88, Keji 1st Rd., Guishan Dist., Taoyuan City 333, Taiwan (R.O.C.)
Company Maxigen Biotech Inc. (MBI) was formed by a group of entrepreneurs and scientists in December 1998. MBI utilizes its core competence in biopolymers and has developed a broad range of applications in areas such as medical devices and skincare products. MBI specializes in the developing, manufacturing, and marketing of biomedical and skincare products. Headquarters was moved to Hua Ya Science park in July, 2016. Our major shareholders include TCI Bio,GIH Group, Formosa Biomedical Technology Corp and – NuVasive Inc., Nasdaq-listed medical device company in the US.

Investor FAQ

  • When was MBI listed and what stock exchange are MBI shares traded on ? What is the ticker symbol

    Listed on December 20th, 2013, MBI shares are traded on Taiwan Exchange Market,under the ticker symbol 1783.

  • What is MBI's fiscal year?

    Our fiscal year ends on December 31th, same as the calendar year.

  • When does MBI announce its monthly sales results and quarterly earnings reports?

    We release monthly sales results by the 10th of each month; first, second and third quarter’s earnings reports within 45 days after the season ends, and annual reports within 3 months after the year ends.

  • Where do investors find MBI's latest and historical financial information?

    Please refer to the Financial Information section or visit the Market Observation Post System.

  • hat is MBI's dividend policy and historical dividend payout?

    The Board of Directors recommends a dividend distribution and the proposal has to be approved at the annual general shareholder’s meeting. MBI’s historical dividend information can be found at the Dividend Payout section.

  • How do investor get information regarding investor conferences?

    MBI announces related information regarding investor conferences on the Market Observation Post System as well as the Investor Conference section on the website.

  • Whom may investor contact for MBI's shareholder services?

    Please contact the transfer agency department of Yuanta Securities Co., Ltd.

    Address: B1F., No. 210, Sec. 3, Chengde Rd., Datong Dist., Taipei City 103432

    Phone: +886-2-2586-5859